Among patients with severe asthma receiving dupilumab for 12 months, 91% had a clinical response and 30% achieved clinical remission.

While the debate continues about the true impact of burning fossil fuels on the climate and what the optimal policy response should be, we need to make sure we do not neglect another aspect of fossil ...

Phase 2 POLARIS trial will evaluate the dosing, safety, and efficacy of HBM9378/WIN378 in patients with asthma, with an ...

Disparities persist in the early introduction of peanut into infant diets despite guidelines, according to a study published in Academic Pediatrics.Equitable guidance from providers may mitigate these ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or 'the Company', HKEX: 6990) today announced that its partner, Windward Bio AG ('Windward Bio') has launched its Phase 2 POLARIS ...

Asthma can impair a child's physical health, education, and emotional well-being, but with early detection and proper ...

The Pentagon says people with congestive heart failure, undergoing treatment for schizophrenia or who have a history of ...

A digital asthma self-management program enhanced symptom control; however, it revealed racial disparities in engagement, highlighting the need for culturally tailored interventions.

The new pill, called AD109, is a combination of atomoxetine and aroxybutynin, two drugs that tell your brain to keep the ...

A digital intervention using the Apple Watch helped people on Medicaid better control their asthma, illustrating the ...

Apnimed has scored another phase 3 knockout. The Massachusetts biotech’s daily pill for obstructive sleep apnea reduced the ...